Mouse Monoclonal ApoA-I antibody [5F4F5] (STJ97832)

$379.00

Reactivity: Human
Applications: WB, ELISA
Conjugation: Unconjugated
Supplier: St John’s Laboratory Ltd.

Clear
-$50 as credit for submitting review for primary antibody
Shipping notice:
Product will be delivered in 6 to 8 Business Days

Mouse Monoclonal ApoA-I antibody [5F4F5] (STJ97832)

Supplier: St John’s Laboratory Ltd.

Recommended applications: WB, ELISA

Recommended dilution: WB 1:500-1:2000; ELISA 1:10000

Recommended protocols: check protocols

Image descriptions:

Click or hover above images to see image description for ApoA-I Monoclonal Antibody.

Alternative names:

Check alternative names for the antibody

Expand

APOA1 antibody,|Apo-AI antibody|ApoA I antibody|ApoA-I antibody|APOA1 antibody|APOA1_HUMAN antibody|Apolipoprotein A-I(1-242) antibody|Apolipoprotein A1 antibody|Apolipoprotein AI antibody|Brp14 antibody|Ltw1 antibody|Lvtw1 antibody|Sep1 antibody|Sep2 antibody|Anti-Apolipoprotein A I antibody [EP1368Y] (ab52945)
SCBT cat No: sc-58230|sc-80551|sc-69755|sc-135837|sc-13549|sc-376818|sc-19029|sc-23605|

 

Name

ApoA-I Monoclonal Antibody

Catalogue No.

STJ97832

Reactivity

Human

Specificity

ApoA-I Monoclonal Antibody detects endogenous levels of ApoA-I protein.

Immunogen

Purified recombinant fragment of human ApoA-I expressed in E Coli

Host

Mouse

Applications

WB, ELISA

Recommended dilution

WB 1:500-1:2000; ELISA 1:10000

Clonality

Monoclonal

Conjugation

Unconjugated

Isotype

IgG1

Formulation

ApoA-I Antibody was tube-contained. Ascitic fluid containing 0.03% sodium azide.

Concentration

1 mg/ml

Purification

ApoA-I Antibody was purified using affinity purification.

Storage

-20 Celsius degree. Avoid repeated freeze/thaw cycles.

Alternative antibody names

Apolipoprotein A-I antibody, Apo-AI antibody, ApoA-I antibody, Apolipoprotein A1 antibody

Database links

Human UniProt/Swiss-Prot:P02647;Mouse UniPort/Swiss-Prot: Q00623;Rat UniProt/Swiss-Port: P04639;Human Entrez Gene: 335;Mouse Entrez Gene: 11806;Rat Entrez Gene: Rn.10308

Protein names

Apolipoprotein A-I , Apo-AI , ApoA-I , Apolipoprotein A1

Protein function

Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility.

Protein tissue specificity

Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine. The oxidized form at Met-110 and Met-136 is increased in individuals with increased risk for coronary artery disease, such as in carrier of the eNOSa/b genotype and exposure to cigarette smoking. It is also present in increased levels in aortic lesions relative to native ApoA-I and increased levels are seen with increasing severity of disease.

Involvement in disease

High density lipoprotein deficiency 2 (HDLD2) [MIM:604091]: Inherited as autosomal dominant trait. It is characterized by moderately low HDL cholesterol, predilection toward premature coronary artery disease (CAD) and a reduction in cellular cholesterol efflux. Note: The disease is caused by mutations affecting the gene represented in this entry.; High density lipoprotein deficiency 1 (HDLD1) [MIM:205400]: Recessive disorder characterized by absence of high density lipoprotein (HDL) cholesterol from plasma, accumulation of cholesteryl esters, premature coronary artery disease (CAD), hepatosplenomegaly, recurrent peripheral neuropathy and progressive muscle wasting and weakness. Note: The disease is caused by mutations affecting the gene represented in this entry.; Note: APOA1 mutations may be involved in the pathogenesis of amyloid polyneuropathy-nephropathy Iowa type, also known as amyloidosis van Allen type or familial amyloid polyneuropathy type III (PubMed:3142462 and PubMed:2123470). The clinical picture is dominated by neuropathy in the early stages of the disease and nephropathy late in the course. Death is due in most cases to renal amyloidosis.; Amyloidosis 8 (AMYL8) [MIM:105200]: A form of hereditary generalized amyloidosis. Clinical features include extensive visceral amyloid deposits, renal amyloidosis resulting in nephrotic syndrome, arterial hypertension, hepatosplenomegaly, cholestasis, petechial skin rash. There is no involvement of the nervous system. . Note: The disease is caused by mutations affecting the gene represented in this entry.

Protein sequence and domain

Belongs to the apolipoprotein A1/A4/E family.

Protein post-translational modifications

Glycosylated. / Palmitoylated. / Phosphorylation sites are present in the extracellular medium.

Protein cellular localization

Secreted

Research area

All research areas>Transport and Trafficking>Apolipoprotein
(View all antibody categories related to Transport and Trafficking)

Note

AntibodyPlus can customize ApoA-I Antibody according to your requirement, including bulk product size,etc. Please contact info@antibodyplus.com. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.

Supplier

St John’s Laboratory Ltd.

Product type

Primary antibody

Reviews


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review

There are no reviews for this product yet.
By submitting a review, get following benefits:

1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!

view database submit reviews

There is no extra validation for this product yet.
Check other extra validated antibodies below:



Welcome to AntibodyPlus!